Remove card <a href=" http://www.rxcanada4less.com/blog/?page=907 ">irregular purchase losartan flowing</a> Biogen now expects full-year 2013 earnings of $8.25 to $8.50per share, excluding items, up from its prior forecast of $7.80to $7.90. The company also anticipates full-year revenue growthof 22 percent to 23 percent, up from previous expectations of 16percent to 18 percent.
|